OrthoAccel Technologies, Inc. Announces New Scientific Advisor

By Orthoaccel Technologies Inc., PRNE
Tuesday, February 22, 2011

HOUSTON, February 23, 2011 - OrthoAccel Technologies, Inc. (www.acceledent.co.uk) developers of
the AcceleDent System (www.acceledent.co.uk), a medical device to
accelerate orthodontic treatment, announced this week that it has engaged Dr.
Dawei Liu (
www.public-health.uiowa.edu/faculty-staff/faculty/directory/faculty-detail.asp?emailAddress=dawei-liu@uiowa.edu)
as a scientific advisor. Dr. Liu's guidance and expertise will help advance
the Company's commitment to a research-focused strategy for developing and
introducing innovative new products.

AcceleDent (www.acceledent.co.uk) is a simple, removable dental
appliance that an orthodontic patient wears in the mouth for 20 minutes daily
to accelerate orthodontic tooth movement (www.acceledent.com). A Phase
I clinical trial in 2008 in Houston, Texas demonstrated the safety and
clinical utility of the device. The first completed AcceleDent case in
private practice
(www.acceledent.co.uk/news/First-AcceleDent-Case-Finished-World-Wide)
was documented last November in the United Kingdom. Dr. Liu's
(www.marquette.edu/dentistry/other/ResearchProfile.shtml) background
is particularly relevant to OrthoAccel's (www.acceledent.co.uk) focus.
His extensive research has centered around the investigation of the effects
of mechanical vibration on orthodontic tooth movement, in an attempt to
shorten the total treatment time and reduce the risk of root resorption in
clinical orthodontic patients. Previously, he accepted an invitation from Dr.
Birte Melsen
(odontologi.au.dk/or/medarbejdereor/profileror/birtemelsen) to work as
a Clinical Assistant Professor at the Department of Orthodontics at the Royal
Dental College in Denmark. Currently, he is the pre-doctoral Program Director
and Research Director at Marquette University in the Department of
Developmental Sciences / Orthodontics.

Michael Lowe, CEO of OrthoAccel (www.acceledent.co.uk), commented,
"At OrthoAccel (www.acceledent.co.uk), we are always looking for ways
to improve our technologies, and to provide the most scientifically advanced
products to our customers. Dr. Liu's scientific research complements
OrthoAccel's (www.acceledent.co.uk) objectives. We believe that he can
effectively guide us toward establishing an evidence-based foundation, which
is an important objective." Dr. Liu
(www.marquette.edu/dentistry/admissions/Faculty.shtml) remarked,
"AcceleDent (www.acceledent.co.uk) has the potential to revolutionize
orthodontics and I am looking forward to working with Management to help
guide OrthoAccel's (www.acceledent.co.uk) future scientific research
strategy."

OrthoAccel's (www.acceledent.co.uk) Management team is traveling
to Europe next month to work on commercialization efforts in several key
markets.

OrthoAccel (www.acceledent.co.uk) has completed a pivotal US
clinical trial at the UT Health Science Center in San Antonio
(orthodontics.uthscsa.edu), and is planning a submission for FDA
clearance on AcceleDent (www.acceledent.co.uk) later this month.

About OrthoAccel Technologies, Inc. (www.acceledent.co.uk)

Based in Houston, Texas, OrthoAccel Technologies, Inc.
(www.acceledent.co.uk) is a privately owned medical device company
currently engaged in the development, manufacturing, and marketing of
products to enhance dental care and orthodontic treatment.

About the AcceleDent (www.acceledent.co.uk) System

AcceleDent (www.acceledent.co.uk) represents the first clinical
approach to safely accelerate orthodontic tooth movement via modulating
biology. The device has been studied clinically and applies gentle pulsing
forces in combination with standard orthodontics to move teeth faster through
accelerated bone remodeling. Importantly, the device works complementary with
all existing orthodontic technologies. AcceleDent
(www.acceledent.co.uk) is neither FDA cleared nor FDA approved; it is
currently investigational only in the United States. More information can be
found at www.acceledent.com or requested via info@orthoaccel.com

Michael K. Lowe, CEO of OrthoAccel Technologies, Inc., +1-832-631-1659

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :